Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Mechanism of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
NCT01950520Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2014
- Primary completion
- Dec 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol, pindolol, dantrolene, magnesium sulfate, caffeine in obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2014; status: completed.
02
Drugs
propranololpindololdantrolenemagnesium sulfatecaffeine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01950520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950520.